No headlines found.
No press releases found.
No news found.
The investment objective of the FT Vest U.S. Equity Max Buffer ETF - April (the "Fund") is to seek to provide investors with returns (before fees and expenses) that match the price return of the SPDR S&P 500 ETF (the "Underlying ETF") up to a predetermined upside cap while seeking to provide the maximum available buffer , against Underlying ETF losses over an approximate period of one year (the "Target Outcome Period"). Over the Target Outcome Period that began on April 21, 2025 and ends on April 17, 2026 the Fund seeks to buffer against the first 100% of Underlying ETF losses and limit gains up to a predetermined upside cap of 7.24%. When the Fund's fees and expenses are taken into account, the cap is 6.39% and the buffer is 99.15%. Fund will invest substantially all of its assets in FLexible EXchange Options ("FLEX Options") that reference the price performance of the Underlying ETF. FLEX Options are customized equity or index option contracts that trade on an exchange, but provide investors with the ability to customize key contract terms like exercise prices, styles and expiration dates.
FT Vest US Equity Max Buffer ETF - April trades on the BATS stock market under the symbol APXM.
As of December 30, 2025, APXM stock price declined to $31.01 with 2,603 million shares trading.
APXM has a market cap of $7.75 million. This is considered a Sub-Micro Cap stock.
APXM support price is $31.01 and resistance is $31.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that APXM shares will trade within this expected range on the day.
